Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Garred

Showing results (251-260 of 290) with videos related to

Pageof 29
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|November 19, 2020
SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent IndividualsCecilie Bo Hansen, Ida Jarlhelt, Laura Pérez-Alós, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2009
Human genetic deficiencies reveal the roles of complement in the inflammatory network: lessons from natureKnut Tore Lappegård, Dorte Christiansen, Anne Pharo, et al.
Frontiers in Immunology|May 10, 2018
Omics-Based Approach Reveals Complement-Mediated Inflammation in Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS)Morten Blaabjerg, Anne Louise Hemdrup, Lylia Drici, et al.
Frontiers in Immunology|December 25, 2024
Unraveling the impact of SARS-CoV-2 mutations on immunity: insights from innate immune recognition to antibody and T cell responsesRafael Bayarri-Olmos, Adrian Sutta, Anne Rosbjerg, et al.
Plos One|April 19, 2013
Association of ficolin-3 with severity and outcome of chronic heart failureZoltán Prohászka, Lea Munthe-Fog, Thor Ueland, et al.
Journal of Internal Medicine|April 6, 2023
SARS-CoV-2 antibody dynamics over time and risk factors associated with infection and long COVID-19 symptoms in large working environmentsCecilie Bo Hansen, Kristina Dvoncova, Laura Pérez-Alós, et al.
BMC Neurology|April 18, 2021
Prediction of survival in amyotrophic lateral sclerosis: a nationwide, Danish cohort studyAnne-Lene Kjældgaard, Katrine Pilely, Karsten Skovgaard Olsen, et al.
Microbiology Spectrum|September 22, 2023
Distinguishing SARS-CoV-2 infection and vaccine responses up to 18 months post-infection using nucleocapsid protein and receptor-binding domain antibodiesIda Jarlhelt, Laura Pérez-Alós, Rafael Bayarri-Olmos, et al.
Open Forum Infectious Diseases|August 16, 2021
SARS-CoV-2 Natural Antibody Response Persists for at Least 12 Months in a Nationwide Study From the Faroe IslandsMaria Skaalum Petersen, Cecilie Bo Hansen, Marnar Fríheim Kristiansen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 24, 2021
SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding DomainRafael Bayarri-Olmos, Manja Idorn, Anne Rosbjerg, et al.
Pageof 29

Showing results (251-260 of 290) with videos related to

Sort By:
Pageof 29
Journal of Immunology (Baltimore, Md. : 1950)|November 19, 2020
SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent IndividualsCecilie Bo Hansen, Ida Jarlhelt, Laura Pérez-Alós, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2009
Human genetic deficiencies reveal the roles of complement in the inflammatory network: lessons from natureKnut Tore Lappegård, Dorte Christiansen, Anne Pharo, et al.
Frontiers in Immunology|May 10, 2018
Omics-Based Approach Reveals Complement-Mediated Inflammation in Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS)Morten Blaabjerg, Anne Louise Hemdrup, Lylia Drici, et al.
Frontiers in Immunology|December 25, 2024
Unraveling the impact of SARS-CoV-2 mutations on immunity: insights from innate immune recognition to antibody and T cell responsesRafael Bayarri-Olmos, Adrian Sutta, Anne Rosbjerg, et al.
Plos One|April 19, 2013
Association of ficolin-3 with severity and outcome of chronic heart failureZoltán Prohászka, Lea Munthe-Fog, Thor Ueland, et al.
Journal of Internal Medicine|April 6, 2023
SARS-CoV-2 antibody dynamics over time and risk factors associated with infection and long COVID-19 symptoms in large working environmentsCecilie Bo Hansen, Kristina Dvoncova, Laura Pérez-Alós, et al.
BMC Neurology|April 18, 2021
Prediction of survival in amyotrophic lateral sclerosis: a nationwide, Danish cohort studyAnne-Lene Kjældgaard, Katrine Pilely, Karsten Skovgaard Olsen, et al.
Microbiology Spectrum|September 22, 2023
Distinguishing SARS-CoV-2 infection and vaccine responses up to 18 months post-infection using nucleocapsid protein and receptor-binding domain antibodiesIda Jarlhelt, Laura Pérez-Alós, Rafael Bayarri-Olmos, et al.
Open Forum Infectious Diseases|August 16, 2021
SARS-CoV-2 Natural Antibody Response Persists for at Least 12 Months in a Nationwide Study From the Faroe IslandsMaria Skaalum Petersen, Cecilie Bo Hansen, Marnar Fríheim Kristiansen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 24, 2021
SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding DomainRafael Bayarri-Olmos, Manja Idorn, Anne Rosbjerg, et al.
Pageof 29